{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:22:52Z","timestamp":1787862172559,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clml.2026.07.003","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:35:13Z","timestamp":1783784113000},"page":"e1069-e1076.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clonal Hematopoiesis in Newly Diagnosed Multiple Myeloma: Associations With Neutropenia, Supportive Care Burden, and Survival"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6216-595X","authenticated-orcid":false,"given":"Ahmet","family":"Yigitbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-0109","authenticated-orcid":false,"given":"Fulya Oz","family":"Puyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7523-8599","authenticated-orcid":false,"given":"Hakki Onur","family":"Kirkizlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-6213","authenticated-orcid":false,"given":"Tugcan Alp","family":"Kirkizlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2554-6432","authenticated-orcid":false,"given":"Nuray","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-7765","authenticated-orcid":false,"given":"Ebru","family":"Tastekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2744-0803","authenticated-orcid":false,"given":"Seyma Keles","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5589-3000","authenticated-orcid":false,"given":"Elif Gulsum","family":"Umit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-5405","authenticated-orcid":false,"given":"Ahmet Muzaffer","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2026.07.003_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clml.2026.07.003_bib0002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41408-022-00645-1","article-title":"Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update","volume":"12","author":"Bazarbachi","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2026.07.003_bib0003","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1200\/EDBK_238527","article-title":"Induction therapy for newly diagnosed multiple myeloma","volume":"39","author":"Paul","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.clml.2026.07.003_bib0004","first-page":"135","article-title":"Real-world risk of severe cytopenias in multiple myeloma patients sequentially treated with immunomodulatory drugs","volume":"148","author":"Barberio","year":"2025","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clml.2026.07.003_bib0005","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2026.07.003_bib0006","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2026.07.003_bib0007","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","article-title":"Somatic mutations precede acute myeloid leukemia years before diagnosis","volume":"24","author":"Desai","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.clml.2026.07.003_bib0008","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2026.07.003_bib0009","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2026.07.003_bib0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/blood.2021013531","article-title":"Association of clonal hematopoiesis with chronic obstructive pulmonary disease","volume":"139","author":"Miller","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.clml.2026.07.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.70123","article-title":"Clinical impact of next-generation sequencing-detected mutations on thrombotic events in myeloproliferative neoplasms","author":"Yigitbasi","year":"2026","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.clml.2026.07.003_bib0012","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/s41467-020-16805-5","article-title":"Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant","volume":"11","author":"Mouhieddine","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.clml.2026.07.003_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79748-7","article-title":"Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis","volume":"14","author":"Gelli","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.clml.2026.07.003_bib0014","first-page":"236","article-title":"Evaluation of CD56 and CD117 double-positivity as a predictor of poor prognosis in multiple myeloma patients: a retrospective analysis","volume":"41","author":"Keski","year":"2024","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.clml.2026.07.003_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4274\/tjh.galenos.2024.2023.0469","article-title":"Do alarmins have a role in multiple myeloma?","volume":"41","author":"Ged\u00fck","year":"2024","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.clml.2026.07.003_bib0016","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2026.07.003_bib0017","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for multiple myeloma: a report from the International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2026.07.003_bib0018","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clml.2026.07.003_bib0019","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.clml.2026.07.003_bib0020","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2026.07.003_bib0021","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2352-3026(17)30140-0","article-title":"Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial","volume":"4","author":"Holstein","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.clml.2026.07.003_bib0022","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1470-2045(18)30687-9","article-title":"Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (myeloma XI): a multicentre, open-label, randomised, phase 3 trial","volume":"20","author":"Jackson","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2026.07.003_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jgo.2016.04.001","article-title":"Management of multiple myeloma in older adults: gaining ground with geriatric assessment","volume":"8","author":"Wildes","year":"2017","journal-title":"J Geriatr Oncol"},{"issue":"8","key":"10.1016\/j.clml.2026.07.003_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2019.04.014","article-title":"Geriatric assessment and frailty scores predict mortality in myeloma: systematic review and meta-analysis","volume":"19","author":"Salazar","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2026.07.003_bib0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.2024026236","article-title":"Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes","volume":"146","author":"Lionetti","year":"2025","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2026.07.003_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2026.04.003","article-title":"Pathogenic and clinical implications of the 2-way interplay between clonal hematopoiesis of indeterminate potential and multiple myeloma","volume":"26","author":"Scopetti","year":"2026","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2026.07.003_bib0027","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/2767-9764.CRC-23-0093","article-title":"Clinical outcomes and evolution of clonal hematopoiesis in patients with newly diagnosed multiple myeloma","volume":"3","author":"Mouhieddine","year":"2023","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.clml.2026.07.003_bib0028","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41375-025-02707-2","article-title":"Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma","volume":"39","author":"Cooperrider","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2026.07.003_bib0029","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/10428194.2014.915544","article-title":"Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone","volume":"56","author":"Sun","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2026.07.003_bib0030","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood.2024027686","article-title":"Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma","volume":"145","author":"Terpos","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.clml.2026.07.003_bib0031","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.1002\/ajh.26125","article-title":"Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapy","volume":"96","author":"Wudhikarn","year":"2021","journal-title":"Am J Hematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026002089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026002089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:48:44Z","timestamp":1787860124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265026002089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2152265026002089"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.07.003","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal Hematopoiesis in Newly Diagnosed Multiple Myeloma: Associations With Neutropenia, Supportive Care Burden, and Survival","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}